Author(s): Sperling RA, Rentz DM, Johnson KA, Karlawish J, Donohue M,
Abstract Share this page
Abstract A new secondary prevention trial in older people with amyloid accumulation at high risk for Alzheimer's disease dementia should provide insights into whether anti-amyloid therapy can delay cognitive decline.
This article was published in Sci Transl Med
and referenced in Journal of Molecular Imaging & Dynamics